Product/Composition:- | Crizotinib Capsules |
---|---|
Strength:- | 200 mg, 250 mg |
Form:- | Oral Capsules |
Reference Brands:- | Xalkori® (US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Crizotinib Capsules are used to treat ALK-positive NSCLC and ROS1-positive cancers, as well as anaplastic large cell lymphoma (ALCL). As a tyrosine kinase inhibitor (TKI), it blocks cancer-causing proteins. Available as Xalkori® in 200 mg and 250 mg strengths, Crizotinib is manufactured under GMP standards, making it a trusted option for oncology treatment in US and EU markets.
Crizotinib Capsules are a targeted therapy used in the treatment of ALK-positive non-small cell lung cancer (NSCLC) and ROS1-positive cancers, as well as anaplastic large cell lymphoma (ALCL). As a tyrosine kinase inhibitor (TKI), Crizotinib blocks the activity of abnormal proteins responsible for cancer cell growth. Marketed under Xalkori®, Crizotinib is available in 200 mg and 250 mg oral capsule strengths. Manufactured under GMP-compliant conditions, it offers a reliable solution for pharmaceutical distributors targeting US and EU oncology markets, providing effective treatment options for precision cancer medicine.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications